Showing results (81-90 of 229) with videos related to

Sort By:
Pageof 23
Transplantation and Cellular Therapy|September 19, 2025
Availability of Suitable Domestic Cord Blood Grafts for Adult Allograft Recipients With Hematologic MalignanciesAnne Archer, Warren B Fingrut, Luzmary Alvarez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Evaluation of Cord Blood Total Nucleated and CD34<sup>+</sup> Cell Content, Cell Dose, and 8-Allele HLA Match by Patient AncestryJuliet N Barker, Christopher M Mazis, Sean M Devlin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2008
Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screenLloyd T Lam, R Eric Davis, Vu N Ngo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2020
Guidelines for Cord Blood Unit SelectionIoannis Politikos, Eric Davis, Melissa Nhaissi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: the phase II VERTICAL studyNathan Fowler, Brad S Kahl, Peter Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2017
Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOPPaolo Strati, Nathan Fowler, Sergio Pina-Oviedo, et al.
British Journal of Haematology|July 22, 2014
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphomaJason R Westin, Peter McLaughlin, Jorge Romaguera, et al.
British Journal of Haematology|July 22, 2014
90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky diseaseFelipe Samaniego, Zuzana Berkova, Jorge E Romaguera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profilingLloyd T Lam, R Eric Davis, Jackie Pierce, et al.
Blood|December 28, 2007
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphomaLloyd T Lam, George Wright, R Eric Davis, et al.
Pageof 23